Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
This research was presented at the American College of Gastroenterology’s annual meeting (ACG 2025), alongside new long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback